Duetact Warnings & Precautions - Duetact Warnings & Precautions

Duetact Warnings & Precautions

WARNINGS
Glimepiride
SPECIAL WARNING ON INCREASED RISK OF CARDIOVASCULAR MORTALITY The administration of oral hypoglycemic drugs has been reported to be associated with increased cardiovascular mortality as compared to treatment with diet alone or diet plus insulin. This warning is based on the study conducted by the University Group Diabetes Program (UGDP), a long-term, prospective clinical trial designed to evaluate the effectiveness of glucose-lowering drugs in preventing or delaying vascular complications in patients with non-insulin-dependent diabetes. The study involved 823 patients who were randomly assigned to one of four treatment groups (Diabetes, 19 supp. 2: 747-830, 1970).

Please visit the website for more information.

WebMD
111 8th Ave
7th Floor
New York, NY 10011
T: (212) 624-3700

Copyright © 2008 by RxList Inc.